Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Biogen Inc

Biogen Inc

BIIB · NASDAQ
BIIB · NASDAQ
250.65
USD6.162.52%

Latest News

    SeekingAlpha

    Biogen to acquire RayThera in deal valued up to $1B

      SeekingAlpha

      Apellis surges on $5.6B buyout deal with Biogen

        MarketWatch

        Stoke Therapeutics and Biogen in pact for treatment for severe form of childhood epilepsy

          SeekingAlpha

          Sage Therapeutics rejects Biogen bid, starts strategic review

            SeekingAlpha

            Sage sues Biogen in wake of $469M buyout offer: report

              MarketWatch

              Biogen and Belgian partner UCB announce positive data from late-stage trial of lupus treatment

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              243.03USD
              258.63USD

              52 Week Range

              138.00USD
              258.63USD

              Market Cap

              37.34BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US09062X1037

              CUSIP

              449370105

              Sector

              Healthcare

              Industry

              Drug Manufacturers - General

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              43.35

              PEG Ratio

              2.61

              Book Value

              127.61

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              5.63

              Wall Street Target Price

              254.17

              EPS Estimate Current Year

              12.44

              EPS Estimate Next Year

              16.37

              EPS Estimate Current Quarter

              1.9779

              EPS Estimate Next Quarter

              3.2676

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              10,027,899,904

              Gross Profit TTM

              7,854,099,968

              EBITDA

              3,359,200,000

              Profit Margin

              8.32%

              Return On Assets TTM

              5.21%

              Return On Equity TTM

              4.58%

              Revenue Per Share TTM

              68.194

              Qtly Revenue Growth YOY

              3.40%

              Diluted Eps TTM

              5.63

              Qtly Earnings Growth YOY

              -84.80%

              Valuation

              Trailing PE

              43.35

              Forward PE

              15

              Price Sales TTM

              3.5959

              Price Book MRQ

              1.9812

              Enterprise Value Revenue

              4

              Enterprise Value EBITDA

              20

              Peers analysis

              • Novartis AG
                NVSEFNovartis AG

                160.00

                6.58%
              • Eli Lilly and Company
                LLYEli Lilly and Company

                1343.54

                3.94%
              • Novartis AG ADR
                NVSNovartis AG ADR

                160.75

                3.09%
              • AstraZeneca PLC
                AZNAstraZeneca PLC

                173.18

                2.24%
              • Merck & Company Inc
                MRKMerck & Company Inc

                143.80

                2.14%
              • AbbVie Inc
                ABBVAbbVie Inc

                291.71

                1.98%
              • Johnson & Johnson
                JNJJohnson & Johnson

                276.40

                1.87%
              • Roche Holding AG
                RHHBFRoche Holding AG

                474.90

                0.00%
              • Roche Holding Ltd ADR
                RHHBYRoche Holding Ltd ADR

                60.22

                -0.25%
              • Roche Holding AG Participation
                RHHVFRoche Holding AG Participation

                480.00

                -0.13%

              Curated watchlists where BIIB is featured.

              FAQs

              What is Biogen stock price today?

              What is Biogen stock ticker?

              Is BIIB stock price going up?

              What is the analyst recommendation for BIIB?

              What is BIIB market cap?

              Does BIIB release financial reports?

              When is BIIB next earnings date?

              What were BIIB Earnings for the last quarter?

              What was BIIB Revenue for the last quarter?

              What was BIIB Net Income for the last quarter?

              Does BIIB pay dividends?

              How many employees does BIIB have?

              What is BIIB EBITDA?

              How to buy BIIB stocks?

              Should I invest in BIIB stock?